QuVa Pharma Inc, a newly formed, national platform for sterile compounding pharmacy services, announces it has completed the acquisition of a manufacturing facility that provides ready-to-use compounded sterile preparations to hospitals across the country. Built to meet stringent state and federal regulations, the modern manufacturing facility is registered as a US FDA outsourcing facility under Section 503B of the Federal Food, Drug, and Cosmetic Act. QuVa Pharma will provide compliance-oriented health care facilities with a reliable supply of quality, safe medications. The company is committed to a patient-first orientation, a robust product portfolio, high safety standards, and collaborative, partnership-oriented customer service.